Clinical Trial Update: Urodynamic and Clinical Efficacy of Mirabegron for Neurogenic Bladder Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reports results from Phase 2/3 studies of mirabegron for neurogenic bladder; the study was terminated and results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder

Drugs mentioned

• Myrbetriq (mirabegron)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Urinary Bladder, Neurogenic | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2019-01-07